ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,734Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1155

$474K Total Retail Price of All Prescriptions

Rank: 57 out of 1155

421 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 8,812 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
OMEPRAZOLE 540 411 1 5
LISINOPRIL 486 377 2 1
SIMVASTATIN 409 330 3 3
LEVOTHYROXINE SODIUM 397 282 4 2
HYDROCODONE-ACETAMINOPHEN 377 297 S3 5 4
AMLODIPINE BESYLATE 336 324 6 6
FUROSEMIDE 333 272 7 8
LOSARTAN POTASSIUM 290 269 8 18
HYDROCHLOROTHIAZIDE 217 188 9 9
METOPROLOL SUCCINATE 214 207 10 17
CITALOPRAM HBR 212 171 11 19
POTASSIUM CHLORIDE 209 182 12 16
LOVASTATIN 209 154 12 13
METFORMIN HCL 205 151 14 7
ATORVASTATIN CALCIUM 204 167 15 12
METOPROLOL TARTRATE 159 128 16 14
WARFARIN SODIUM 146 145 17 11
GABAPENTIN 136 87 18 15
DONEPEZIL HCL 126 102 19 41
LANTUS 119 88 20 39
ATENOLOL 117 117 21 10
SERTRALINE HCL 107 83 22 24
SPIRONOLACTONE 94 76 23 55
ZOLPIDEM TARTRATE 91 87 24 21
POLYETHYLENE GLYCOL 3350 88 61 25 59
FENTANYL 84 83 S2 26 64
FLUOXETINE HCL 83 59 27 30
TRAZODONE HCL 82 74 28 22
NAMENDA 81 81 29 67
KLOR-CON M20 78 51 30 131
DILTIAZEM 24HR CD 78 78 30 109
LEVOXYL 77 77 32 118
PREDNISONE 72 67 33 40
PRAVASTATIN SODIUM 71 59 34 20
DIVALPROEX SODIUM 69 41 35 106
CARVEDILOL 69 56 35 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 57 37 26
CARBIDOPA-LEVODOPA 62 62 38 124
CLONIDINE HCL 62 62 38 69
LACTULOSE 61 37 40 122
JANUVIA 59 59 41 127
ALENDRONATE SODIUM 58 37 42 25
LANTUS SOLOSTAR 57 55 43 96
MIRTAZAPINE 56 44 44 61
OXYCODONE HCL 56 24 S2 44 23
CRESTOR 55 46 46 34
QUETIAPINE FUMARATE 53 27 47 77
TERAZOSIN HCL 50 38 48 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.